Laurence E. Reid
2013
In 2013, Laurence E. Reid earned a total compensation of $1.2M as Senior Vice President and Chief Business Officer at Alnylam Pharmaceuticals, a 25% increase compared to previous year.
Compensation breakdown
Bonus | $25,000 |
---|---|
Non-Equity Incentive Plan | $161,250 |
Option Awards | $645,154 |
Salary | $375,000 |
Other | $7,182 |
Total | $1,213,586 |
Reid received $645.2K in option awards, accounting for 53% of the total pay in 2013.
Reid also received $25K in bonus, $161.3K in non-equity incentive plan, $375K in salary and $7.2K in other compensation.
Rankings
In 2013, Laurence E. Reid's compensation ranked 5,806th out of 12,286 executives tracked by ExecPay. In other words, Reid earned more than 52.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,806 out of 12,286 | 53rd |
Division Manufacturing | 2,016 out of 4,612 | 56th |
Major group Chemicals And Allied Products | 590 out of 1,462 | 60th |
Industry group Drugs | 423 out of 1,156 | 63rd |
Industry Pharmaceutical Preparations | 341 out of 890 | 62nd |
Source: SEC filing on April 29, 2014.
Reid's colleagues
We found four more compensation records of executives who worked with Laurence E. Reid at Alnylam Pharmaceuticals in 2013.
2013
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2013
Barry Greene
Alnylam Pharmaceuticals
Chief Operating Officer
2013
Akshay Vaishnaw
Alnylam Pharmaceuticals
Chief Medical Officer
2013
Michael Mason
Alnylam Pharmaceuticals